LENZ Therapeutics (LENZ) Institutional Ownership → LEAKED: Jeff Bezos' $330 Million Gamble (From Behind the Markets) (Ad) Free LENZ Stock Alerts $15.29 -0.22 (-1.42%) (As of 05/31/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for LENZ Therapeutics (NASDAQ:LENZ)CurrentInstitutional OwnershipPercentage54.32%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$105.64MNumber ofInstitutional Sellers(last 12 months)0 Get LENZ Insider Trade Alerts Want to know when executives and insiders are buying or selling LENZ Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LENZ Institutional Buying and Selling by Quarter Ad Porter & CompanyThe only financial event in 2024 that matters Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here LENZ Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 RA Capital Management L.P.4,178,823$93.31M1.2%N/A114.488% 5/17/2024 Ikarian Capital LLC85,000$1.90M0.2%N/A2.329% 5/16/2024 Jacobs Levy Equity Management Inc.37,176$830K0.0%N/A1.019% 5/14/2024 American International Group Inc.1,973$44K0.0%N/A0.054% 5/10/2024 Vanguard Group Inc.206,952$4.62M0.0%N/A5.670% 5/7/2024 Marquette Asset Management LLC5,865$131K0.0%N/A0.161% 5/2/2024 Jennison Associates LLC134,740$3.01M0.0%N/A3.692% 5/1/2024 BNP Paribas Financial Markets16,221$362K0.0%N/A0.444% 4/25/2024 BML Capital Management LLC63,916$1.43M0.9%N/A1.751% (Data available from 1/1/2016 forward) LENZ Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LENZ shares? During the previous two years, 9 institutional investors and hedge funds held shares of LENZ Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($93.31M), Vanguard Group Inc. ($4.62M), Jennison Associates LLC ($3.01M), Ikarian Capital LLC ($1.90M), BML Capital Management LLC ($1.43M), Jacobs Levy Equity Management Inc. ($830K), and BNP Paribas Financial Markets ($362K).Learn more on LENZ's institutional investors. What percentage of LENZ Therapeutics stock is owned by institutional investors? 54.32% of LENZ Therapeutics stock is owned by institutional investors. Learn more on LENZ's institutional investor holdings. Which institutional investors have been buying LENZ Therapeutics stock? Of the 9 institutional investors that purchased LENZ Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($4.18M), Vanguard Group Inc. ($206.95K), Jennison Associates LLC ($134.74K), Ikarian Capital LLC ($85K), BML Capital Management LLC ($63.92K), Jacobs Levy Equity Management Inc. ($37.18K), and BNP Paribas Financial Markets ($16.22K). How much institutional buying is happening at LENZ Therapeutics? Institutional investors have bought a total of 4,730,666 shares in the last 24 months. This purchase volume represents approximately $105.64M in transactions. Related Companies: ELEV Institutional Ownership IPHA Institutional Ownership IVVD Institutional Ownership CHRS Institutional Ownership GLUE Institutional Ownership SCLX Institutional Ownership CMPX Institutional Ownership CGEN Institutional Ownership INMB Institutional Ownership FENC Institutional Ownership This page (NASDAQ:LENZ) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENZ Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
